In cosmetic science, peptides are short chains of amino acids, usually between two and twenty residues, that are studied as ingredients because they mimic or modulate signals between skin cells. The main groups are signal peptides, carrier peptides, neurotransmitter-modulating peptides and enzyme inhibitors, each acting by a different proposed mechanism. So what are peptides in skincare, scientifically? They are defined sequences with measurable mass, purity and stability, and their behaviour is investigated in cell culture, reconstructed skin models and permeation experiments. This article explains the chemistry and naming, the mechanisms, the published laboratory evidence, and the handling requirements that make results reproducible.
What are peptides in skincare? Classes, names and structures
A peptide is a polymer of amino acids joined by amide bonds, and its sequence, written from the N-terminus to the C-terminus, fixes its charge, hydrophobicity and activity. The average residue contributes about 110 daltons, so the short chains used in cosmetic research typically weigh between 300 and 1,000 daltons. That mass range is central to the field, as the penetration discussion below explains.
Cosmetic ingredient names follow the International Nomenclature of Cosmetic Ingredients (INCI), which labels peptides by chain length and any modification. A name such as palmitoyl pentapeptide-4 describes a five-residue chain carrying a palmitoyl group, while acetyl hexapeptide-8 describes a six-residue chain with an acetylated N-terminus. The same molecule may therefore appear under an INCI name in a formulation and under its sequence in a research catalogue.
Four functional groups dominate the literature. Signal peptides mimic fragments released when matrix proteins are broken down, and are proposed to prompt cells to synthesise matrix components. The best-known example is the pentapeptide with the sequence lysine-threonine-threonine-lysine-serine, derived from the C-terminal propeptide of type I procollagen. With a palmitoyl chain attached, its mass is about 802 daltons. Carrier peptides bind metal ions, and glycyl-L-histidyl-L-lysine (GHK) is the principal example. The peptide weighs about 340 daltons, and its copper(II) complex about 403. Loren Pickart and colleagues first isolated GHK from human plasma in 1973. Neurotransmitter-modulating peptides, such as acetyl hexapeptide-8, with the sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2 and a mass near 889 daltons, are designed from the SNAP-25 protein of the SNARE complex that controls vesicle fusion. Enzyme-inhibitor peptides are designed to block proteases such as matrix metalloproteinases.
Chemical modification is widespread. Palmitoylation adds a 16-carbon fatty acyl group of about 238 daltons, which makes a peptide more lipophilic. Acetylation and amidation cap the termini to resist exopeptidases, and metal complexation changes both mass and charge. These changes are deliberate design choices, and each one has consequences for solubility, stability and analytical characterisation.
Mechanism of action
The proposed mechanisms differ by class, and it is important to separate what has been demonstrated in cells from what is hypothesised.
Signal peptides are thought to act through the matrikine concept. When collagen is cleaved by proteases, the released fragments may act as feedback signals to fibroblasts, which then increase synthesis of matrix proteins. The receptors for most of these fragments have not been fully characterised, so the mechanism remains partly inferential. In cell culture, the response is measured through collagen or hydroxyproline output, or through transcript levels of matrix genes.
Carrier peptides such as GHK-Cu are proposed to deliver copper, a cofactor for lysyl oxidase and other enzymes, and to alter gene expression. The peptide has been linked in cell-culture work to changes in matrix proteins and their regulators. Neurotransmitter-modulating peptides are proposed to compete with SNAP-25 for a position in the SNARE complex, and the evidence for this sits mainly in neuronal and secretory cell models.
A separate question concerns reaching the target. The stratum corneum is a lipid-rich barrier, and Bos and Meinardi argued in 2000 that compounds above about 500 daltons cannot cross it. Many peptides exceed that mass, so researchers study whether lipidation, carrier systems or formulation changes the picture. Skin enzymes such as aminopeptidases can also cleave small peptides, which means that stability in a skin model is part of the mechanism and not a side issue. For these reasons, conclusions about any single peptide depend on the model, the formulation and the analytical verification of the material, and a result in a cell monolayer does not translate automatically to a barrier model.
What the research shows
Four areas of published work illustrate how cosmetic peptides are investigated. Readers should consult the primary papers for methods and data.
The first is the 1988 study by Maquart and colleagues in FEBS Letters, which examined GHK-Cu in fibroblast cultures. The stimulation of collagen synthesis began between 10⁻¹² and 10⁻¹¹ M, peaked at 10⁻⁹ M and was independent of any change in cell number. The authors noted that a GHK sequence occurs within type I collagen and suggested the tripeptide might be liberated by proteases at an injury site. The record is on PubMed.
The second is the 2018 review by Pickart and Margolina in the International Journal of Molecular Sciences, which summarises cell-culture and gene-expression data on GHK-Cu. It reports that human adult dermal fibroblasts incubated with 0.01, 1 and 100 nM GHK-Cu showed increased production of elastin and collagen, increased MMP1 and MMP2 expression at the lowest concentration, and increased TIMP1 at all concentrations. The review also covers other material, including studies that are not laboratory work, and only the cell-culture findings are relied upon here. It is open access on PubMed Central.
The third is the paper by Bos and Meinardi, a review-style argument rather than an experiment. The authors proposed that a compound must be under 500 daltons to allow skin absorption, citing the fact that virtually all common contact allergens and topical pharmacological agents fall below that mass. The paper is widely cited in cosmetic science, although later work shows that penetration also depends on lipophilicity, formulation and barrier condition, so the figure is a guide and not a fixed limit. The record is on PubMed.
The fourth is permeation work on copper peptides. Researchers have reported mass-spectrometry studies of how a GHK-copper complex moves through model stratum corneum membranes, and further work on the skin penetration ability of copper-peptide complexes. These used artificial membranes and diffusion systems rather than living tissue, and they are described here in general terms; readers should read the original papers, since transport depends heavily on the model.
Research applications
Laboratories use cosmetic-ingredient peptides in several kinds of work. In cell biology, cultured dermal fibroblasts and epidermal keratinocytes are treated with peptides and assessed by hydroxyproline assay, ELISA, quantitative PCR and immunoblotting, with readouts such as collagen, elastin, glycosaminoglycan and matrix metalloproteinase expression. Reconstructed human epidermis and full-thickness skin equivalents allow researchers to study behaviour across tissue layers without using animals.
In permeation science, Franz diffusion cells and tape-stripping methods are used to measure how much of a peptide crosses or accumulates in a membrane, usually quantified by LC-MS. In formulation research, peptides serve as model compounds for studying stability in emulsions and gels, including degradation by pH, oxidation and enzymes. In analytical chemistry, they act as reference standards for method development.
UK researchers should also be aware of the regulatory context. Cosmetic products placed on the UK market must be safe, have a responsible person and carry substantiated claims, and a product whose presentation implies treating or preventing disease may be treated as a medicine instead. The Medicines and Healthcare products Regulatory Agency assesses this case by case, looking at labelling, packaging, promotional literature and advertisements, including websites. Its borderline products guidance sets out the approach. This is general information rather than legal advice. A research peptide, supplied as a laboratory reagent, is a different thing from a finished cosmetic product, and the two should not be conflated.
Purity, storage and handling
Purity verification starts with reversed-phase HPLC, usually with UV detection at 214 or 220 nm, which separates the target from deletion sequences, truncated chains and incompletely deprotected by-products and reports purity as the percentage of the total peak area belonging to the target. A figure of 98% or higher is commonly specified for cell-based assays, but HPLC alone does not prove identity, so it should be paired with mass spectrometry confirming that the observed mass matches the theoretical value. For metal complexes, the copper-to-peptide ratio is an additional quality attribute, and for lipidated peptides, the correct attachment of the acyl group should be confirmed by mass.
A batch-specific certificate of analysis matters because synthesis is never perfectly repeatable. Two lots of the same sequence can differ in purity, counter-ion content, water content and net peptide content, and a generic specification sheet cannot capture that variation. A proper certificate lists the lot number, chromatogram, mass-spectrometry result and analysis date, so a result can be traced to a specific vial. Because the same sequence can be supplied either as a cosmetic raw material or as a laboratory reagent, researchers who ask what are peptides in skincare should check which specification applies, and for research-grade material should expect a batch-specific certificate of analysis and lyophilised storage at -20°C; the checks for comparing suppliers are set out in How to buy best peptides.
Lyophilised peptides are most stable when dry, sealed and cold. Storage at -20°C is the usual recommendation for the long term, and -80°C is sometimes preferred for sensitive sequences. Vials should be brought to room temperature in a desiccator before opening, because condensation introduces moisture that promotes hydrolysis. Sequences containing methionine, as in acetyl hexapeptide-8, are prone to oxidation, while those containing asparagine or glutamine can deamidate over time.
Reconstituted peptides are far less stable than the dry powder. Stock solutions are normally prepared in sterile water or a suitable buffer, divided into single-use aliquots and frozen to avoid repeated freeze-thaw cycles. Palmitoylated peptides are hydrophobic and may need a small proportion of an organic solvent such as DMSO, matched against the tolerance of the assay. Copper-binding peptides need extra care, because chelating agents such as EDTA and thiol-containing reagents can remove the metal and change behaviour. Light sensitivity is a further consideration, since tryptophan, tyrosine and some labelled peptides can undergo photo-oxidation, and copper complexes can change under prolonged exposure. Vials are best kept in the dark or in amber glass, and each aliquot should be labelled with the date, lot number and concentration.
Frequently asked questions
Are peptides in skincare the same as research peptides?
Not necessarily. Cosmetic ingredient peptides are manufactured to raw-material specifications and regulated as components of finished cosmetic products, whereas research peptides are supplied as laboratory reagents with analytical documentation. The same sequence can appear in both, but purity expectations, documentation and legal status differ, so the two should not be treated as interchangeable.
Can peptides penetrate the stratum corneum?
Bos and Meinardi proposed in 2000 that compounds above about 500 daltons cannot cross the stratum corneum, and many peptides exceed that mass. Lipid modification and formulation are studied as ways to alter permeation, but it remains an experimental question, measured in vitro with diffusion cells and skin models, and results depend on the model used.
What does palmitoyl mean in a peptide name?
Palmitoyl is a 16-carbon fatty acyl group, usually attached to the N-terminus or a lysine side chain. It adds about 238 daltons and makes the peptide more lipophilic, which is intended to alter how it interacts with lipid membranes. It also changes solubility, so palmitoylated peptides often need different solvents from unmodified sequences.
How should lyophilised peptides be stored?
Keep lyophilised peptides sealed, dry and protected from light, usually at -20°C for long-term storage. Allow vials to reach room temperature in a desiccator before opening so condensation does not add moisture. Copper-containing peptides should avoid chelators such as EDTA, and solutions should be divided into single-use aliquots to avoid repeated freeze-thaw cycles.
The compounds discussed in this article are supplied for in-vitro laboratory research only and are not for human or veterinary use.